Any stock, in context
SPARC · Healthcare
Sun Pharma Advanced Research Company Ltd.
Observation · 15 Oct 2026
How these are readSun Pharma Advanced Research Company closed at ₹188.3 on 15 Oct 2026, 7.5% above its 200-day average and 5.3% below its 50-day average: above the long line, below the short one. It sits 32.2% below its highest close of the past year, in the middle fifth of its one-year range. Over three months it fell 19.9%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +7.5%
- the long line
- vs 50-day
- −5.3%
- the short line
- From 52w high
- −32.2%
- ₹108.0₹289.0
- 3 months
- −19.9%
- sector median −2.7% · 133 of 146
Nifty Microcap 250 · Healthcare · EQ series · median traded value ₹17 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −1.82%
- 1W
- –
- 1M
- +0.17%
- 3M
- −19.94%
- YTD
- –
- 1Y
- +43.44%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.